Logo-bma
Biomed adv. 2025;2(3): 104-130. doi: 10.34172/bma.29

Review Article

miRNA-Loaded stem cell-derived exosomes in neuroregeneration: Current insights and future perspectives

Ayse Melis Ozdemir ORCID, Helin Lara Senoglu ORCID, Mohammadreza Dastouri * ORCID

Cited by CrossRef: 0

1- Elias A, Stern S. Gene Editing Strategies for Neurological and Mental Disorders: Advances in Delivery, Methodology, and Clinical Translation. Cells. 2026;15(8):720 [Crossref]
2- Saçaki C, Lührs L, Dziedzic D, da Rosa N, De Rosa A, de Oliveira Souza Sartori C, Irioda A, Mogharbel B, de Carvalho K. Therapeutic Potential of Exosomal miRNAs from Mesenchymal Stem Cells for Neurodegenerative Diseases: A Systematic Review. Curr Tissue Microenviron Rep. 2026;7(1) [Crossref]

Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with